What does an elevated NT‑proBNP indicate in a 73‑year‑old man with a preserved ejection fraction of 60‑65% and grade 1 diastolic dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

NT-proBNP of 968 pg/mL in a 73-Year-Old Male with Preserved EF and Grade 1 Diastolic Dysfunction

This NT-proBNP level of 968 pg/mL indicates the presence of heart failure with preserved ejection fraction (HFpEF) with underlying diastolic dysfunction, and warrants treatment initiation and close monitoring for disease progression.

Interpretation Based on Guidelines

Your patient's NT-proBNP of 968 pg/mL exceeds the diagnostic threshold for HFpEF. According to ESC guidelines, NT-proBNP >125 pg/mL in the non-acute setting supports the diagnosis of HFpEF when combined with preserved EF and symptoms/signs of heart failure 1. The American Heart Association recommends age-adjusted cutoffs, and for patients aged 50-75 years, the rule-in threshold is 900 pg/mL 2. At age 73, your patient's value of 968 pg/mL clearly exceeds this threshold.

Clinical Significance of This Specific Value

The NT-proBNP level of 968 pg/mL in the context of:

  • Preserved EF (60-65%): Rules out systolic dysfunction
  • Grade 1 diastolic dysfunction: Confirms early diastolic impairment with elevated filling pressures
  • Age 73: Falls within the intermediate-risk category

This combination indicates HFpEF with mild-to-moderate severity. Research demonstrates that NT-proBNP correlates directly with diastolic dysfunction severity, with grade 1 dysfunction typically showing values in the 300-1000 pg/mL range 3. Your patient's value sits at the upper end of this spectrum, suggesting he may be at risk for progression to more severe grades.

Prognostic Implications

This NT-proBNP level independently predicts adverse outcomes including:

  • Increased risk of heart failure hospitalization 4
  • Higher mortality risk compared to patients with lower values 5
  • Likelihood of progression to more severe diastolic dysfunction 3

The biomarker demonstrates strong correlation with left ventricular filling pressures (r=0.40, p<0.0001) 6, meaning this elevated value reflects genuine hemodynamic abnormality, not a false positive.

Important Caveats for This Patient

Age-related considerations: Recent population-based studies show that apparently healthy adults aged 70-74 can have NT-proBNP values up to 824 ng/L (men) as the 97.5th percentile 7. However, your patient's value of 968 pg/mL exceeds even this upper reference limit, and combined with documented grade 1 diastolic dysfunction, confirms pathologic elevation rather than age-related variation.

Common confounders to exclude:

  • Atrial fibrillation: Increases NT-proBNP by 2.59-fold 4 - check rhythm
  • Renal dysfunction: Reduced clearance elevates levels - verify eGFR >60 mL/min/1.73m²
  • Obesity: Paradoxically lowers NT-proBNP - if BMI >30, the true cardiac stress may be underestimated 2
  • Acute decompensation: This value suggests chronic stable HFpEF rather than acute presentation

Clinical Action Plan

Immediate steps:

  1. Confirm HFpEF diagnosis - Patient meets all ESC criteria 1:

    • Symptoms/signs of HF (verify presence of dyspnea, exercise intolerance, or edema)
    • Preserved EF ≥50% ✓
    • Elevated NT-proBNP >125 pg/mL ✓
    • Structural/functional cardiac abnormality (grade 1 diastolic dysfunction) ✓

  2. Initiate guideline-directed therapy for HFpEF focusing on:

    • Aggressive blood pressure control
    • Volume management with diuretics if congestion present
    • Treatment of comorbidities (diabetes, obesity, atrial fibrillation)

  3. Risk stratification - This intermediate NT-proBNP level (not extremely high but clearly elevated) suggests moderate risk requiring 3-6 month follow-up

  4. Serial monitoring - Repeat NT-proBNP in 3-6 months; rising values predict worsening diastolic function and increased hospitalization risk 3

Pitfall to Avoid

Do not dismiss this as "normal for age." While NT-proBNP increases with aging, values >800-900 pg/mL in a 73-year-old with documented diastolic dysfunction represent true pathology requiring intervention 7, 4. The negative predictive value of NT-proBNP is excellent (94-98%), but the positive predictive value in this context—combined with echocardiographic confirmation—makes the diagnosis highly reliable 1.

The combination of NT-proBNP 968 pg/mL + grade 1 diastolic dysfunction + preserved EF definitively establishes HFpEF diagnosis and mandates treatment to prevent progression to more severe heart failure stages.

References

Related Questions

In a patient with grade 1 diastolic dysfunction, normal left ventricular size, normal left atrial volume index, low BNP and NT‑proBNP, an E/e′ of approximately 9 (rising), and a low peak velocity‑time integral (~22 cm), does grade 1 indicate that the heart is working harder and less efficiently, and could increased afterload be the primary contributor?
What is the best approach to diagnose and manage a patient with normal BNP levels, unmeasured NT-proBNP levels, grade 1 diastolic dysfunction, low stroke volume index, mild pitting edema, and bilateral partial numbness of the toes?
I have grade 1 diastolic dysfunction and mild stable concentric left‑ventricular hypertrophy, no symptoms, and an NT‑proBNP < 36 pg/mL; what management and follow‑up should I pursue?
In a patient with grade 1 diastolic dysfunction, do B-type natriuretic peptide levels below 100 pg/mL and N-terminal pro‑B‑type natriuretic peptide levels below 300 pg/mL reliably exclude clinically overt heart failure?
Can a patient have an NT‑proBNP (N‑terminal pro‑B‑type natriuretic peptide) level of about 16 000 pg/mL and be asymptomatic, and is a dose of BMX 3 mg twice daily safe?
What are the magnetic resonance cholangiopancreatography (MRCP) findings characteristic of autoimmune pancreatitis?
In a pregnant woman requiring antihypertensive therapy, how does nifedipine compare to labetalol in terms of efficacy, dosing, contraindications, and safety for mother and fetus?
What loading dose of colistimethate sodium (colistin) should be administered to a typical 70‑kg adult with normal renal function?
Which baseline laboratory tests should be obtained after a potential exposure (e.g., needle‑stick or unprotected sexual contact) to assess human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis, and other sexually transmitted infections (STIs), and to evaluate suitability for post‑exposure prophylaxis?
What is the recommended non‑occupational post‑exposure prophylaxis (nPEP) regimen and testing schedule for HIV exposure?
What antibiotic is appropriate for a carbuncle with black necrotic tissue on top?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.